These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24336135)

  • 1. Extent and effects of recurrent shortages of purified-protein derivative tuberculin skin test antigen solutions - United States, 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(49):1014-5. PubMed ID: 24336135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National shortage of purified-protein derivative tuberculin products.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Apr; 62(16):312. PubMed ID: 23615675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide Shortage of Tuberculin Skin Test Antigens: CDC Recommendations for Patient Care and Public Health Practice.
    MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(24):552-553. PubMed ID: 31220054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in tuberculin skin test converters among health care workers after a change from Tubersol to Aplisol.
    Gillenwater KA; Sapp SC; Pearce K; Siberry GK
    Am J Infect Control; 2006 Dec; 34(10):651-4. PubMed ID: 17161740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in tuberculin reactivity as determined in a veterans administration employee health screening program.
    Mehta SR; MacGruder C; Looney D; Johns S; Smith DM
    Clin Vaccine Immunol; 2009 Apr; 16(4):541-3. PubMed ID: 19225075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing interferon- gamma release assay with tuberculin skin test readings at 48-72 hours and 144-168 hours with use of 2 commercial reagents.
    Tat D; Polenakovik H; Herchline T
    Clin Infect Dis; 2005 Jan; 40(2):246-50. PubMed ID: 15655742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
    Villarino ME; Burman W; Wang YC; Lundergan L; Catanzaro A; Bock N; Jones C; Nolan C
    JAMA; 1999 Jan; 281(2):169-71. PubMed ID: 9917121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis.
    Duchin JS; Jereb JA; Nolan CM; Smith P; Onorato IM
    Clin Infect Dis; 1997 Sep; 25(3):661-3. PubMed ID: 9314456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Future supply of tuberculin in Germany].
    Sagebiel D; Hauer B; Haas W; Magdorf K; Priwitzer M; Loddenkemper R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):477-82. PubMed ID: 15830261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European shortage of purified protein derivative and its impact on tuberculosis screening practices.
    Tebruegge M; Buonsenso D; Brinkmann F; Noguera-Julian A; Pavić I; Arbore AS; Vančíková Z; Velizarova S; Welch SB; Ritz N;
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1293-1299. PubMed ID: 27725037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-positive tuberculin skin tests in a state prison system.
    Grabau JC; Hughes SE; Foster EA; Kearns CH; Klopf L
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):93-7. PubMed ID: 12701841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous comparison of reactivity to purified protein derivative RT-23 and Tubersol in health care workers in Vitória, Brazil.
    Teixeira L; Maciel E; Dutra ME; Perkins MD; Johnson JL; do Valle Dettoni V
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1074-7. PubMed ID: 11092721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different methods and times for reading the tuberculin skin test.
    Morán-Mendoza O; Tello-Zavala MC; Rivera-Camarillo M; Ríos-Meza Y
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1273-8. PubMed ID: 24025377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of tuberculin skin test (TST) in vervet monkeys (Chlorocebus pygerythrus) using experimentally tuberculin sensitized animals.
    Hablolvarid MH; Eslampanah M; Mosavari N; Baradaran-Seyed Z
    J Med Primatol; 2019 Aug; 48(4):218-225. PubMed ID: 31012123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculin testing in a tertiary hospital: product variability.
    Shands JW; Boeff D; Fauerbach L; Gutekunst RR
    Infect Control Hosp Epidemiol; 1994 Dec; 15(12):758-60. PubMed ID: 7890924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-Positive Tuberculin Skin Test Results Among Low-Risk Healthcare Workers Following Implementation of Fifty-Dose Vials of Purified Protein Derivative.
    Collins JM; Hunter M; Gordon W; Kempker RR; Blumberg HM; Ray SM
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):750-752. PubMed ID: 29606170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients.
    Dogan E; Erkoc R; Sayarlioglu H; Uzun K
    Ren Fail; 2005; 27(4):425-8. PubMed ID: 16060131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012.
    Miramontes R; Hill AN; Yelk Woodruff RS; Lambert LA; Navin TR; Castro KG; LoBue PA
    PLoS One; 2015; 10(11):e0140881. PubMed ID: 26536035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin test of tuberculin purified protein derivatives with a dissolving microneedle-array patch.
    Wang W; Liu HM; Zhou J; Wang YG; Feng X; Tang H; Yan Q; Zhu RS; Wu YW; Wang XG; He D; Chen F
    Drug Deliv Transl Res; 2019 Aug; 9(4):795-801. PubMed ID: 30891708
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.